CVE Tools
Track your stack

CVE-2023-38952

Public exploit available. Not confirmed exploited in the wild yet. A vendor fix is available.

CVSS 3.17.5HighEPSS percentile86th2.7% chance in 30 daysCISA KEVNot listedNo confirmed exploitation
Public exploit: 1 sourceFixVendor fixNo build named by the sources

Published Updated Sources: CVE.org, NVD, BDU

NVD CVE.org

What to do

The vendor has published a fix. Version details are below where the sources state them.

  • ZKTECO CO., LTD BioTimeAffected: 8.5.5Upgrade to: not statedStated by: BDU

Versions as the sources state them. Full version matrix after sign-in

Check it yourselfA free Nuclei and OpenVAS check exists for this CVE. Run it against your hosts.Is your organisation exposed?Discuss checks for your systems with a specialist. Scope is agreed before testing.

What it is

From the CVE record

Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.

In plain language

No plain-language summary for this CVE yet.

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS86th
Public exploit
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

1 source with a proof of concept or module.

Exploit links, PoCs and Metasploit modules after sign-in
EPSS

2.7% chance of exploitation activity in the next 30 days, which ranks it in the 86th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

A public exploit existed 120 days before the patch.

  1. Patch availablerecord updated
  2. Patch availablerecord updated
  3. OpenVAS check added
  4. EPSS band changemoderate → low
  5. Public exploit / PoCsource: github-pocnuclei check added
  6. Publishedweakness classified, att&ck mapped

Affected products

And 1 more affected product. See all after sign-in

Technical detail

CVSS 3.1 vector

Open in the CVSS calculator

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Scored 7.5 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required NoneNo authentication required — anyone can exploit this
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope UnchangedImpact is limited to the vulnerable component itself

Impact if exploited

  • Confidentiality HighTotal information disclosure — all data in the component is compromised
  • Integrity NoneNo integrity impact
  • Availability NoneNo availability impact

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

References in the record

And 2 more references. See all after sign-in

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for BioTime, not every advisory. This one: public exploit.